VBI Vaccines, Inc. (NASDAQ: VBIV) is a biopharmaceutical company developing new technologies in order to expand vaccine protection in large, underserved markets. The company’s eVLP vaccine platform allows for the design of vaccines that closely mimic the target virus. The company’s lead eVLP asset is a prophylactic Cytomegalovirus vaccine. The company’s second platform is a thermostable technology that enables the development of vaccines that can withstand fluctuating temperatures. For more information, visit the company’s website at www.vbivaccines.com.

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its tenth annual equity conference in Sandpiper Bay, FL. Attended by institutional investors from across North America, the event features more than 140 public company executive teams from a diverse range of industries. For more information, visit www.noble.missionir.com.